Description

Denipim (cefepime) powder for solution for injections 1000 mg. №1 vial

Ingredients

Active ingredient: Cefepime. Inactive ingredients may include lactose.

Dosage

Dosage: The usual adult dose is 1 to 2 grams every 12 hours. Dosage adjustments may be needed based on the severity of the infection.

Indications

Indications: Denipim is indicated for the treatment of moderate to severe infections caused by susceptible bacteria.

Contraindications

Contraindications: Do not use Denipim if there is a known allergy to cefepime or other cephalosporins.

Directions

Administration: Denipim is administered by intravenous infusion over 30 minutes. Follow the healthcare provider’s instructions.

Scientific Evidence

Pharmacological Effects: Cefepime, the active ingredient in Denipim, is a fourth-generation cephalosporin with broad-spectrum activity against many Gram-positive and Gram-negative bacteria. It exerts its bactericidal effects by inhibiting bacterial cell wall synthesis.

Clinical Trials: Clinical studies have demonstrated the efficacy of cefepime in treating various infections, including pneumonia, urinary tract infections, and intra-abdominal infections. For example, a study published in the Journal of Antimicrobial Chemotherapy showed that cefepime was effective in treating febrile neutropenia in cancer patients.

Additional Information

Storage: Store Denipim vials at room temperature away from light and moisture.

Precautions: Use with caution in patients with renal impairment as dosage adjustments may be necessary.

• Discuss the risks and benefits of Denipim with your healthcare provider before use.
• Report any allergic reactions or severe side effects to your healthcare provider immediately.